Mitsui has patented a sequence analysis method for analyzing nucleic acid sequences. The method involves aligning read sequences with a reference sequence containing rearrangement sequences. The reference sequence is updated with new mutation information for accurate analysis. GlobalData’s report on Mitsui gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Mitsui & Co Ltd - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Mitsui, Hydrogen storage alloys was a key innovation area identified from patents. Mitsui's grant share as of February 2024 was 51%. Grant share is based on the ratio of number of grants to total number of patents.

Sequence analysis method for nucleic acid sequences with rearrangement sequences

Source: United States Patent and Trademark Office (USPTO). Credit: Mitsui & Co Ltd

A recently granted patent (Publication Number: US11901043B2) discloses a sequence analysis method for analyzing nucleic acid sequences. The method involves obtaining read sequences from a sequencer device, aligning them with a reference sequence containing rearrangement sequences, updating the reference sequence with new mutation information, and determining the nucleic acid sequences. The method allows for the analysis of mutations, polymorphisms, and methylation in the sequences, providing a comprehensive approach to sequence analysis.

Furthermore, the patent also describes a sequence analysis apparatus and a reference sequence generation apparatus that facilitate the implementation of the sequence analysis method. These devices are equipped with processing devices to handle the alignment of read sequences, updating of reference sequences with new mutation information, and determination of nucleic acid sequences. By incorporating known mutation information from a database, the apparatus ensures accurate and up-to-date analysis of nucleic acid sequences. Overall, the patent presents a sophisticated method and apparatus for sequence analysis, offering a valuable tool for researchers and professionals in the field of genomics and molecular biology.

To know more about GlobalData’s detailed insights on Mitsui, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Patent Analytics tracks patent filings and grants from official offices around the world. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.